Niaid preclinical development support - production of a chimpanzee adenovirus HIV-1 vaccine
Active Awarded Last action
- Contract number
- HHSN27200037
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,447,235
Award facts
- Contract value 100% obligated
- $4,447,235.00 Current and potential, with all options
- Completion date 84% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $0 | |
| Change Order | $331,050 | |
| Definitize Change Order | $115,549 | |
| Definitize Change Order | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $2,120,046 | |
| Original award | $1,880,590 |
About this award
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract, valued at $4,447,235.00, is for the production of a chimpanzee adenovirus HIV-1 vaccine as part of NIAID's preclinical development support program. The contract does not have a set-aside designation. ABL, which has been awarded numerous federal contracts and grants, particularly from NIH and HHS, will provide a range of goods and services to support the preclinical and clinical development of this HIV vaccine, including cGMP manufacturing, process development, analytical testing, and project management. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) with NIAID, indicating ABL's broad capabilities in supporting the development of vaccines, therapeutics, and diagnostics across multiple disease areas and federal health agencies.
Quick answers
Who was awarded contract HHSN27200037?
HHSN27200037 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2016.
How much is contract HHSN27200037 worth?
The government has obligated $4,447,235 on HHSN27200037.
Is contract HHSN27200037 an order under another contract?
Yes. HHSN27200037 is a delivery order under HHSN272201100021I, an indefinite delivery contract.
Was contract HHSN27200037 competed?
The extent of competition for HHSN27200037 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award